Abstract
OBJECTIVES:This study was conducted to clarify the rate of late diagnosis of HIV infection and to identify relationships between the reasons for HIV testing and a late diagnosis.METHODS:This retrospective cohort study was conducted among HIV-positive patients at the Jikei University Hospital between 2001 and 2014. Patient characteristics from medical records, including age, sex, sexuality, the reason for HIV testing and the number of CD4-positive lymphocytes at HIV diagnosis, were assessed.RESULTS:A total of 459 patients (men, n=437; 95.2%) were included in this study and the median age at HIV diagnosis was 36 years (range, 18–71 years). Late (CD4 cell count <350/mm3) and very late (CD4 cell count <200/mm3) diagnoses were observed in 61.4% (282/459) and 36.6% (168/459) of patients, respectively. The most common reason for HIV diagnosis was voluntary testing (38.6%, 177/459 patients), followed by AIDS-defining illness (18.3%, 84/459 patients). Multivariate analysis revealed a significant association of voluntary HIV testing with non-late and non-very-late diagnoses and there was a high proportion of AIDS-defining illness in the late and very late diagnosis groups compared with other groups. Men who have sex with men was a relative factor for non-late diagnosis, whereas nonspecific abnormal blood test results, such as hypergammaglobulinemia and thrombocytopenia, were risk factors for very late diagnosis.CONCLUSIONS:Voluntary HIV testing should be encouraged and physicians should screen all patients who have symptoms or signs and particularly hypergammaglobulinemia and thrombocytopenia, that may nonspecifically indicate HIV infection.
Highlights
With the development of antiretroviral therapy (ART), the mortality and morbidity associated with HIV have decreased [1]
Previous studies have shown that survival improved with early initiation of ART [3,4] and that ART initiation at CD4 counts o500/mm3 improved the course of HIV infection [5]
We present the results of the logistic regression analysis as an adjusted odds ratio (AOR) with a 95% confidence interval (CI)
Summary
With the development of antiretroviral therapy (ART), the mortality and morbidity associated with HIV have decreased [1]. Lohse et al demonstrated an estimated median survival of 435 years for a young HIV-positive individual [2]. Previous studies have shown that survival improved with early initiation of ART [3,4] and that ART initiation at CD4 counts o500/mm improved the course of HIV infection [5]. Late diagnosis and delayed treatment of HIV infection contribute to the development of opportunistic infections, such as pneumocystis pneumonia and cytomegalovirus infection and increase hospitalization and mortality risks [6,7,8]. Reduction of HIV viral load by early.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have